Integrated care, international expansion, growth outside of kidney care, and demographics are driving the company's future. "The aging of America for most of what we do is going to lead to more demand for our services," says Thiry. "This is particularly true in kidney care because diabetes and hypertension are the biggest causes of kidney failure…Our mission is however, to help prevent that; to help prevent kidney failure, to help prevent other chronic illnesses and at the same time reduce costs and improve quality once people have them." DaVita is certainly doing their best to make those better treatments a reality, but they're in a very competitive business and keeping this stock growing will be no easy task for Thiry and his team. Is there a company you would like to see profiled? Let us know in the comments below or on our Facebook page.